Skip to main content
. 2015 Jul 14;10(7):e0132656. doi: 10.1371/journal.pone.0132656

Table 2. Characteristic measures of the dry-eye syndrome after three months treatment with Conheal.

Month 3* Comparison Month 3 vs Month 0 Comparison Month 3 vs Month 1
Mean±SD Shift parameter** and 95% CI P value*** Shift parameter** and 95% CI P value***
right left right left right left right left right left
LIPCOF degree 1.4±0.6 1.4±0.7 -2.0(-2.0 to -1.0) -1.0(-2.0 to -1.0) <0.001 <0.001 0.0(-1.0 to 0.0) 0.0(0.0 to 0.0) 0.035 0.312
TFBUT value 5.9±2.3 5.7±1.8 1.1(0.2 to 2.0) 0.9(0.3 to 1.5) 0.020 0.004 0.5(-0.3 to 1.3) -0.0(-0.7 to 0.6) 0.191 0.953
Oxford grade 0.3±0.4 0.2±0.4 -1.0(-1.0 to -1.0) -1.0(-1.0 to -1.0) <0.001 <0.001 0.0(-1.0 to 0.0) 0.0(-1.0 to 0.0) 0.016 0.039
OSDI Score 15.6±16.7 -13.1(-25.0 to -8.3) <0.001 -2.4(-5.7 to 0.0) 0.012

*LIPCOF degrees, TFBUT values, Oxford Scheme grades and OSDI scores were measured, and statistical analysis was performed as described in Methods. For Month 0 and Month 1 values, see Table 1.

**This column contains the median difference and its nonparametric CI for LIPCOF, Oxford and OSDI (Corresponding to the Wilcoxon Signed Rank test), whereas it contains the mean difference and 95% CI based on the t-distribution for TFBUT

***P-value of the Wilcoxon Signed Rank Test for LIPCOF, Oxford and OSDI, and P-value of the paired t-test for TFBUT (two-sided). Gray boxes represent the non-significant changes.